SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
IMMUCELL CORP
(NQSC:ICCC Last Sale: 4.48 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (ICCC : $4.48)
$32,314 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today
56 Evergreen Drive Research Report Earnings Snapshot - Last 05/14/17
Portland, ME 04103 Fact Sheet
Phone: (207) 878-2770 Financial Statements
Peer Comparison
Annual Reports

Thomas G. Adelman, Chmn., Thomas Hatch, Pres./CEO, Michael F. Brigham, CFO
ImmuCell Corporation is a biotechnology company that develops, manufactures, and markets milk-derived passive antibody products to prevent gastrointestinal disease in both humans and animals. Sells other products to dairy and cattle farmers.
Historical Charts    Technical Analysis
No Historical Data available for ICCC

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ICCC $4.48 $4.48 0 .0 $4.48 $4.67 2,093 $4.48 $4.67 7,212,919
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $32,313,877

A76
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex